In mice, the destruction of islet cells with streptozotocin triggered hyperglycemia, intravascular oxidative stress, DNA breaks, PARP activation, and a selective loss of endothelium-dependent vasodilation. The gene discussed is PARP1; the disease is Hyperglycemia.